María Luisa Martínez Ginés

Safety and efficacy of tolebrutinib, an oral brain-penetrant BTK inhibitor, in relapsing multiple sclerosis: a phase 2b, randomised, double-blind, placebo-controlled trial

Daniel S. Reich, Douglas L. Arnold, Patrick Vermersch et al. · The Lancet Neurology · 2021 · 192 citations · Full text

Medicine, Neurology, Pharmacology +9

Risk and outcomes of COVID‐19 in patients with multiple sclerosis

Irene Moreno‐Torres, Virginia Meca‐Lallana, Lucienne Costa‐Frossard et al. · European Journal of Neurology · 2021 · 36 citations · Full text

Veterinary Medicine, Infectious Diseases, Internal Medicine +11

Neurofilament light chain levels in pregnant multiple sclerosis patients: a prospective cohort study

Juan Pablo Cuello, María Luisa Martínez Ginés, Jens Kühle et al. · European Journal of Neurology · 2019 · 25 citations

Life Sciences, Neurology, Neuroscience +15

Elevated plasma fibrinogen levels in multiple sclerosis patients during relapse

Milagros Hidalgo de la Cruz, Alberto Lozano Ros, Saskia Prasca Tapia et al. · Multiple Sclerosis and Related Disorders · 2017 · 21 citations

Life Sciences, Clinical Sciences, Neurology +14

ICANS risk model in CD19 CAR-T therapy: insights from serum and CSF cytokine profiling

Marina Gómez-Llobell, Carlos Serra Smith, Daniel Gómez-Costas et al. · Bone Marrow Transplantation · 2025 · 14 citations · Full text

Life Sciences, Immunology, Neurology +17